Kim et al., 2023 - Google Patents
The salivary and nasopharyngeal microbiomes are associated with SARS‐CoV‐2 infection and disease severityKim et al., 2023
View HTML- Document ID
- 13296275713677374020
- Author
- Kim J
- Zhang A
- Rauseo A
- Goss C
- Mudd P
- O'Halloran J
- Wang L
- Publication year
- Publication venue
- Journal of medical virology
External Links
Snippet
Emerging evidence suggests the oral and upper respiratory microbiota may play important roles in modulating host immune responses to viral infection. As the host microbiome may be involved in the pathophysiology of coronavirus disease 2019 (COVID‐19), we …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zuo et al. | Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge | |
| Zhang et al. | Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications | |
| Wang et al. | Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions | |
| Wu et al. | Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization | |
| Tao et al. | Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18 | |
| Kim et al. | The salivary and nasopharyngeal microbiomes are associated with SARS‐CoV‐2 infection and disease severity | |
| Lehtinen et al. | Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge | |
| Ko et al. | Acute exacerbation of COPD | |
| Lewnard et al. | Prevention of coronavirus disease 2019 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and severe acute respiratory syndrome coronavirus 2 in the respiratory tract | |
| Abrahamsson et al. | Low gut microbiota diversity in early infancy precedes asthma at school age | |
| Van Beek et al. | Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratory-confirmed influenza virus infections | |
| Braman | Postinfectious cough: ACCP evidence-based clinical practice guidelines | |
| Yang et al. | Alterations in oral microbiota in HIV are related to decreased pulmonary function | |
| Albrich et al. | A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2 | |
| Kageyama et al. | Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID‑19: A single‑arm, double‑blind, prospective trial combined with an in vitro cytokine response assay | |
| Gao et al. | Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions | |
| Syed et al. | Gastrointestinal pathophysiology of SARS-CoV2–a literature review | |
| Lalloo et al. | HIV and COPD: a conspiracy of risk factors | |
| Zhao et al. | The human respiratory microbiome: current understandings and future directions | |
| Giugliano et al. | NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy | |
| Ufberg et al. | Aspiration of gastric contents: association with prehospital intubation | |
| Qi et al. | Lower respiratory tract microbial composition was diversified in Pseudomonas aeruginosa ventilator-associated pneumonia patients | |
| Maddah et al. | Evaluation of the gut microbiome associated with COVID-19 | |
| Ghosh et al. | Does periodontitis influence the risk of COVID‐19? A scoping review | |
| Van Beveren et al. | The respiratory microbiome in childhood asthma. |